These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1303805)

  • 1. Clinical relevance of immunologic findings in cutaneous lupus erythematosus.
    Blaszczyk M; Jablonska S; Chorzelski TP; Jarzabek-Chorzelska M; Beutner EH; Kumar V
    Clin Dermatol; 1992; 10(4):399-406. PubMed ID: 1303805
    [No Abstract]   [Full Text] [Related]  

  • 2. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
    Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
    J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chilblain lupus erythematosus associated with systemic and discoid lupus erythematosus.
    Cardenas-de la Garza JA; Arvizu-Rivera RI; Ocampo-Candiani J; Galarza-Delgado DA
    Rheumatology (Oxford); 2021 Feb; 60(2):988. PubMed ID: 32856084
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic evaluation of the lupus band test in discoid and systemic lupus erythematosus.
    George R; Kurian S; Jacob M; Thomas K
    Int J Dermatol; 1995 Mar; 34(3):170-3. PubMed ID: 7751090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing subacute cutaneous from other types of lupus erythematosus.
    McCauliffe DP
    Lancet; 1998 May; 351(9115):1527-8. PubMed ID: 10326532
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of interleukin-17 is correlated with interferon-α expression in cutaneous lesions of lupus erythematosus.
    Oh SH; Roh HJ; Kwon JE; Lee SH; Kim JY; Choi HJ; Lim BJ
    Clin Exp Dermatol; 2011 Jul; 36(5):512-20. PubMed ID: 21631571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation.
    Lehmann P; Hölzle E; Kind P; Goerz G; Plewig G
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):181-7. PubMed ID: 2179293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discoid lupus erythematosus--variants and clinical associations.
    Callen JP
    Clin Dermatol; 1985; 3(3):49-57. PubMed ID: 3880023
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertrophic lupus erythematosus complicating long-standing systemic lupus erythematosus.
    Bernardi M; Bahrami S; Callen JP
    Lupus; 2011 Apr; 20(5):549-50. PubMed ID: 21300682
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in patients with Lupus erythematosus: spectrum and frequencies.
    Wenzel J; Bauer R; Bieber T; Böhm I
    Dermatology; 2000; 201(3):282-3. PubMed ID: 11096213
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous lupus erythematosus in India: immunofluorescence profile.
    George R; Mathai R; Kurian S
    Int J Dermatol; 1992 Apr; 31(4):265-9. PubMed ID: 1634292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet light and cutaneous lupus.
    Bijl M; Kallenberg CG
    Lupus; 2006; 15(11):724-7. PubMed ID: 17153842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subacute cutaneous lupus erythematosus based on a study of 15 cases].
    Marschalkó M; Dobozy E; Daróczy J; Gyimesi E; Horváth A
    Orv Hetil; 1989 Dec; 130(49):2623-8. PubMed ID: 2689950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of lupus erythematosus.
    Błaszczyk M; Majewski S; Wasik M; Chorzelski T; Jabłonska S
    Br J Dermatol; 1987 Dec; 117(6):709-14. PubMed ID: 3426951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct immunofluorescence in lupus erythematosus (LE).
    Isfer RS; Sanches Júnior JA; Festa Neto C; Cernea SS; de Oliveira ZN; Vilela MA; Silva ML; Miyachi LM; Fukumori LM; da Silva SR
    Sao Paulo Med J; 1996; 114(2):1141-7. PubMed ID: 9077025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of specific cutaneous manifestations in patients with lupus erythematosus: a time for change? The concept of dermal lupus erythematosus.
    Lipsker D
    Dermatology; 2006; 212(4):324-6. PubMed ID: 16707881
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous immunofluorescence.
    Weigand DA
    Med Clin North Am; 1989 Sep; 73(5):1263-74. PubMed ID: 2671545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.
    Vazquez T; Patel J; Kodali N; Diaz D; Bashir MM; Chin F; Keyes E; Sharma M; Sprow G; Grinnell M; Dan J; Werth VP
    J Invest Dermatol; 2024 Jun; 144(6):1262-1272.e7. PubMed ID: 38086428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.